Detalles de la búsqueda
1.
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial.
Lancet
; 401(10392): 1929-1940, 2023 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37156252
2.
Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal-bolus insulin regimens in treat-to-target trials: A narrative review.
Diabet Med
; 41(7): e15339, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38679910
3.
Basal Insulin Degludec and Glycemic Control Compared to Aspart Via Insulin Pump in Type 1 Diabetes (BIGLEAP): A Single-Center, Open-Label, Randomized, Crossover Trial.
Endocr Pract
; 28(2): 165-172, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34763071
4.
Social determinants of health, personalized medicine, and child maltreatment.
Pediatr Res
; 89(2): 368-376, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33288877
5.
Interorganizational Knowledge Sharing to Establish Digital Health Learning Ecosystems: Qualitative Evaluation of a National Digital Health Transformation Program in England.
J Med Internet Res
; 23(8): e23372, 2021 08 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34420927
6.
Exploring the Burden of Mealtime Insulin Dosing in Adults and Children With Type 1 Diabetes.
Clin Diabetes
; 39(4): 347-357, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34866778
7.
The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mL.
Diabetes Obes Metab
; 22(5): 779-787, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31903697
8.
Theoretical and methodological considerations in evaluating large-scale health information technology change programmes.
BMC Health Serv Res
; 20(1): 477, 2020 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32460830
9.
Technological Capabilities to Assess Digital Excellence in Hospitals in High Performing Health Care Systems: International eDelphi Exercise.
J Med Internet Res
; 22(8): e17022, 2020 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32808938
10.
Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia in insulin-treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials.
Diabetes Obes Metab
; 21(3): 622-630, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30362250
11.
A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5).
Diabetes Obes Metab
; 21(4): 961-967, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30537180
12.
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial.
JAMA
; 318(1): 33-44, 2017 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28672316
13.
Reduced risk of hypoglycemia with insulin degludec versus insulin glargine in patients with type 2 diabetes requiring high doses of basal insulin: a meta-analysis of 5 randomized begin trials.
Endocr Pract
; 20(4): 285-92, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24246344
14.
Prevalence, trends, and factors associated with maternal autonomy regarding healthcare, finances, and mobility in Bangladesh: Analysis of Demographic and Health Surveys 1999-2018.
PLOS Glob Public Health
; 4(2): e0002816, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38306319
15.
How Should Clinicians and Health Care Organizations Promote Equity in Child Abuse and Neglect Suspicion, Evaluation, and Reporting?
AMA J Ethics
; 25(2): E133-140, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36754076
16.
Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes-Reply.
JAMA
; 318(18): 1828-1829, 2017 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29136440
17.
Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial.
Diabetes Ther
; 13(4): 761-774, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35290624
18.
Benefits realization management in the context of a national digital transformation initiative in English provider organizations.
J Am Med Inform Assoc
; 29(3): 536-545, 2022 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34927692
19.
SGLT-2 INHIBITORS AS ADJUNCT THERAPY IN TYPE 1 DIABETES: REASON FOR HOPE AND CAUTION.
Endocr Pract
; 22(3): 371-3, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26595514
20.
Cost effectiveness of SEEK: A primary care-based child maltreatment prevention model.
Child Abuse Negl
; 111: 104809, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33203542